Application of deubiquitinating enzyme USP45 in preparation of medicine for treating esophageal cancer
A technology for deubiquitinating enzymes and esophageal cancer, applied in the field of biomedicine, can solve the problems of no research revealing the mechanism of action of USP45
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0021] The features and advantages of the present invention can be further understood from the following detailed description in conjunction with the accompanying drawings. The description is an explanation of the content of the invention and does not in any way limit the rest of the disclosure of the invention.
[0022] The basis for supporting the content protected by the present invention is given below.
[0023] 1. Experimental methods and experimental operations
[0024] 1. Bioinformatics analysis
[0025] Normalized RNA-Seq data for esophageal cancer were downloaded from the TCGA database via UCSC Xena (https: / / xena.ucsc.edu / ). RNA-Seq data of human normal tissues were downloaded from the GTEx database (https: / / commonfund.nih.gov / GTEx). We further extracted the expression data of ENSG00000123552 (USP45) gene in each sample according to the filtering principle of normal solid tissue, primary solid tumor, primary tumor and normal tissue. Then, log2(x+1) transformation ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com